相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
Harmanjit Singh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter
Boglarka Zambo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
A novel fluorescence-based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third-generation P-gp inhibitors and OATP1A2
Eva Bakos et al.
FEBS JOURNAL (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
Dan M. Roden et al.
CIRCULATION (2020)
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
What Do We Know About Remdesivir Drug Interactions?
Katherine Yang
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions
Virag Szekely et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yu-chen Cao et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19
Sarah C. J. Jorgensen et al.
PHARMACOTHERAPY (2020)
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Craig R. Rayner et al.
ANTIVIRAL RESEARCH (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta
Lenka Tupova et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
Katya Uzunova et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics
Sarah Billington et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices
Ondrej Martinec et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism
Orsolya Mozner et al.
CELLS (2019)
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
Jeong-Joong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions
Edit Szabo et al.
PLOS ONE (2018)
Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1
Izabel Patik et al.
SCIENTIFIC REPORTS (2018)
The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions
Daniella Kovacsics et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings
Jingjing Yu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2
Noora Sjostedt et al.
PHARMACEUTICAL RESEARCH (2017)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Application of fluorescent dye substrates for functional characterization of ABC multidrug transporters at a single cell level
Zsuzsanna Nerada et al.
CYTOMETRY PART A (2016)
Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2
Chenghao Xu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Expression of Organic Anion Transporting Polypeptide 1A2 in Red Blood Cells and Its Potential Impact on Antimalarial Therapy
Andrea Hubeny et al.
DRUG METABOLISM AND DISPOSITION (2016)
ABCG2 DYSFUNCTION INCREASES SERUM URIC ACID BY DECREASED INTESTINAL URATE EXCRETION
Tappei Takada et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2014)
Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
J. Jacob Strouse et al.
ANALYTICAL BIOCHEMISTRY (2013)
Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication
Lindsay Lundberg et al.
ANTIVIRAL RESEARCH (2013)
Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
Yoshihisa Shitara et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
K. M. Giacomini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
A P-gp vesicular transport inhibition assay - Optimization and validation for drug-drug interaction testing
Krisztina Heredi-Szabo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
The SLCO (former SLC21) superfamily of transporters
Bruno Hagenbuch et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
DyeCycle violet used for side population detection is a substrate of P-glycoprotein
Maximilian Boesch et al.
CYTOMETRY PART A (2012)
Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug - Drug Interactions
Maria Karlgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines
Wouter F. W. Bierman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
pH Dependence of Organic Anion-Transporting Polypeptide 2B1 in Caco-2 Cells: Potential Role in Antiretroviral Drug Oral Bioavailability and Drug-Drug Interactions
Olena Kis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
Ruben C. Hartkoorn et al.
PHARMACOGENETICS AND GENOMICS (2010)
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
P. Annaert et al.
XENOBIOTICA (2010)
Blood-brain barrier transporters and response to CNS-active drugs
Bradley L. Urquhart et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice
J. Geyer et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)
Gergely Szakacs et al.
DRUG DISCOVERY TODAY (2008)
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier
Sandrine Dauchy et al.
JOURNAL OF NEUROCHEMISTRY (2008)
ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS
M. Daood et al.
NEUROPEDIATRICS (2008)
Quantitative atlas of membrane transporter proteins:: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria
Junichi Kamiie et al.
PHARMACEUTICAL RESEARCH (2008)
Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family
B. Hagenbuch et al.
XENOBIOTICA (2008)
Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites
Andrew J. Slot et al.
DRUG METABOLISM AND DISPOSITION (2008)
Lopinavir-Ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma
G. Corona et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter
Agnes Telbisz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes
Omar Janneh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor
Sheetal Agarwal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Modulation of human BCRP (ABCG2) activity by anti-HIV drugs
Johanna Weiss et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Side population analysis using a violet-excited cell-permeable DNA binding dye
William G. Telford et al.
STEM CELLS (2007)
Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader Exons and promoters
Yang Zong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human multidrug resistance ABCB and ABCG transporters:: Participation in a chemoimmunity defense system
Balazs Sarkadi et al.
PHYSIOLOGICAL REVIEWS (2006)
Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
A Lespine et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2)
A Gupta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter -: Modulation of substrate specificity by a point mutation
C Özvegy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins
GJEJ Hooiveld et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene
KL Mealey et al.
PHARMACOGENETICS (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells
C Özvegy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
分享论文
